Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience - PubMed (original) (raw)
. 2017 Nov;40(11):1723-1731.
doi: 10.1007/s00270-017-1694-1. Epub 2017 May 16.
Affiliations
- PMID: 28512687
- DOI: 10.1007/s00270-017-1694-1
Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience
Amar C Gupta et al. Cardiovasc Intervent Radiol. 2017 Nov.
Abstract
Purpose: Transjugular intrahepatic portosystemic shunts (TIPS) were historically placed using uncovered bare-metal stents. Current practice has now shifted toward the use of polytetrafluoroethylene (PTFE)-covered stents, given the improved primary patency seen with these stents. The aim of this study was to determine whether there is any added value, such as overall survival or stent patency, when using covered stents versus uncovered stents in TIPS placement in a large cohort.
Materials and methods: From April 1995 to June 2012, a total of 744 consecutive adult patients underwent de novo TIPS placement (378 receiving uncovered stents, 366 receiving covered stents). Information was obtained on demographics, baseline clinical variables, and outcomes after TIPS placement. Data were collected, compared, and analyzed to assess outcomes including mortality, primary patency (determined via repeat intervention), and secondary patency (determined via ultrasound parameters).
Results: Covered stents were associated with significantly improved primary patency (P < 0.001) and secondary patency (P < 0.001) when compared with uncovered stents in TIPS procedures. Additionally, covered stents were associated with higher estimated overall survival rates and higher survival rates when TIPS was performed emergently and in patients with higher Model for End-Stage Liver Disease (MELD) scores. For example, in patients with MELD scores between 11 and 18, there was a predicted survival of 59.2% with covered stents versus 42.8% with uncovered stents at 1 year.
Conclusion: This study demonstrated that covered stents offer the additional value of higher estimated overall survival and higher estimated survival in patients undergoing TIPS emergently and in those with higher MELD scores when compared to uncovered stents.
Keywords: Cirrhosis; Liver; Portal vein hypertension; Stent; TIPS.
Similar articles
- Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene-covered stent versus bare stent in transjugular intrahepatic portosystemic shunt.
Huang Q, Wu X, Fan X, Cao J, Han J, Xu L, Li N. Huang Q, et al. J Clin Ultrasound. 2010 Sep;38(7):353-60. doi: 10.1002/jcu.20709. J Clin Ultrasound. 2010. PMID: 20533444 Clinical Trial. - Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D. Yang Z, et al. J Gastroenterol Hepatol. 2010 Nov;25(11):1718-25. doi: 10.1111/j.1440-1746.2010.06400.x. J Gastroenterol Hepatol. 2010. PMID: 21039832 - Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J, Ripoll C, Bañares R, Echenagusia A, Catalina MV, Camúñez F, Simó G, Santos L. Barrio J, et al. Eur J Radiol. 2005 Jul;55(1):120-4. doi: 10.1016/j.ejrad.2004.10.007. Eur J Radiol. 2005. PMID: 15950109 - Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis.
Triantafyllou T, Aggarwal P, Gupta E, Svetanoff WJ, Bhirud DP, Singhal S. Triantafyllou T, et al. J Laparoendosc Adv Surg Tech A. 2018 Jul;28(7):867-879. doi: 10.1089/lap.2017.0560. Epub 2018 Jan 22. J Laparoendosc Adv Surg Tech A. 2018. PMID: 29356589 Review. - [Covered transjugular intrahepatic portosystemic shunts].
García-Pagán JC. García-Pagán JC. Gastroenterol Hepatol. 2006 Dec;29(10):647-51. doi: 10.1157/13095210. Gastroenterol Hepatol. 2006. PMID: 17198643 Review. Spanish.
Cited by
- Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft.
Perello MP, Mur JP, Vives MS, Riutort JMM, Artigues AP, Garcia CN, Vidal MLB, Gelabert AE, Garau MV. Perello MP, et al. Diagn Interv Radiol. 2019 Sep;25(5):346-352. doi: 10.5152/dir.2019.18416. Diagn Interv Radiol. 2019. PMID: 31322502 Free PMC article. - Imaging-guided interventions modulating portal venous flow: Evidence and controversies.
Cannella R, Tselikas L, Douane F, Cauchy F, Rautou PE, Duran R, Ronot M. Cannella R, et al. JHEP Rep. 2022 Apr 4;4(7):100484. doi: 10.1016/j.jhepr.2022.100484. eCollection 2022 Jul. JHEP Rep. 2022. PMID: 35677591 Free PMC article. Review. - Managing portal hypertension in patients with liver cirrhosis.
Sauerbruch T, Schierwagen R, Trebicka J. Sauerbruch T, et al. F1000Res. 2018 May 2;7:F1000 Faculty Rev-533. doi: 10.12688/f1000research.13943.1. eCollection 2018. F1000Res. 2018. PMID: 29780579 Free PMC article. Review. - Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding.
Pandhi MB, Kuei AJ, Lipnik AJ, Gaba RC. Pandhi MB, et al. Semin Intervent Radiol. 2020 Mar;37(1):3-13. doi: 10.1055/s-0039-3402015. Epub 2020 Mar 4. Semin Intervent Radiol. 2020. PMID: 32139965 Free PMC article. Review. - Applying Principles of Regenerative Medicine to Vascular Stent Development.
Selvakumar PP, Rafuse MS, Johnson R, Tan W. Selvakumar PP, et al. Front Bioeng Biotechnol. 2022 Mar 7;10:826807. doi: 10.3389/fbioe.2022.826807. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35321023 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous